Treating prostate cancer with testosterone, HU0000261A2 - Módszer prosztatatúltengés és prosztatarák kezelésére - Google Patents

Abirateron-acetát

A prosztatitis kezelése műveletek nélkül

The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Studies on prostatic cancer. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Nem állhat a prosztatitisből

Cancer Res. Treatment strategies for advanced prostate cancer. Actualities in the medical treatment of metastatic prostate cancer.

prostata ingrossata intervento laser

Novelties in diagnostics and treatment of prostate cancer. Androgen-deprivation therapy alone or with docetaxel Népi jogorvoslatok kezelésére prosztatitis non-castrate metastatic prostate cancer GETUG-AFU 15 : a randomised, open-label, phase 3 trial. Lancet Oncol.

Prosztata kezelési só

J Clin Oncol. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer.

Tárolási prosztatitis kezelése

N Engl J Med. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer STAMPEDE : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

Lancet ; — Eur Urol.

HU0000261A2 - Módszer prosztatatúltengés és prosztatarák kezelésére - Google Patents

Ann Oncol. Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer.

Panteop prosztatitis

Abiraterone and increased survival in metastatic prostate cancer. Abiraterone in metastatic prostate cancer without previous chemotherapy. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer.

One of the treatment options for advanced prostate cancer is androgen deprivation therapy, which uses drugs to lower levels of the hormones that help prostate cancer cells grow. Current FDA-approved treatments of this type are injected or placed as small implants under the skin. Orgovyx is an orally administered treatment that works by blocking the pituitary gland from making hormones called luteinizing hormone and follicle-stimulating hormone, thereby reducing the amount of testosterone the testicles are able to make.

Abiraterone for prostate cancer not previously treated with hormone therapy. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.

Prostate Cancer Prostatic Dis.

Olvassa el is